UK markets close in 4 hours 45 minutes

Merrimack Pharmaceuticals, Inc. (MACK)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
15.130.00 (0.00%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
200,460
-1,181
-1,544
-2,455
-3,028
-
Depreciation & amortisation
-
-
-
-
-
2,228
Deferred income taxes
-
-
-
-
-
-1,500
Stock-based compensation
191
160
71
397
1,722
-
Change in working capital
125
-64
176
1,984
-1,180
-
Accounts receivable
-
-
-
-
-
0
Accounts payable
103
-148
27
-208
-1,944
-
Other working capital
-2,480
-1,522
-1,742
-218
-4,625
-
Other non-cash items
-
-298
-
-
-
141
Net cash provided by operating activities
-2,480
-1,522
-1,742
-218
-4,625
-
Cash flows from investing activities
Purchases of investments
-
-18,588
0
-
-
0
Sales/maturities of investments
9,000
6,000
0
-
-
51,500
Net cash used for investing activities
215,412
-12,449
445
144
2,139
-
Cash flows from financing activities
Debt repayment
-
-
-
-
-
-15,000
Dividends paid
-
-
-
-
-
-26,700
Other financing activities
-
-
-
-
-56
-985
Net cash used provided by (used for) financing activities
1,827
521
6,533
239
-56
-
Net change in cash
214,759
-13,450
5,236
165
-2,542
-
Cash at beginning of period
19,401
19,439
14,203
14,038
16,580
-
Cash at end of period
234,160
5,989
19,439
14,203
14,038
-
Free cash flow
Operating cash flow
-2,480
-1,522
-1,742
-218
-4,625
-
Free cash flow
-2,480
-1,522
-1,742
-218
-4,625
-